Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
AMRX
Stock Latest News
Company Announcements
Amneal Pharma Bets Big On Biosimilars Growth
7d ago
AMRX
Premium
Pre-Earnings
Is AMRX a Buy, Before Earnings?
8d ago
AMRX
Premium
Company Announcements
Amneal to Acquire Kashiv, Expanding Biosimilars Platform
15d ago
8K
AMRX
Premium
The Fly
Amneal Pharmaceuticals raises FY26 adjusted EPS view to 95c-$1.05 from 93c-$1.03
15d ago
AMRX
Premium
The Fly
Amneal Pharmaceuticals to acquire Kashiv BioSciences
15d ago
AMRX
Premium
The Fly
Amneal Pharmaceuticals reports Q1 adjusted EPS 27c, consensus 17c
15d ago
AMRX
Premium
The Fly
Amneal announces additional interim Phase 4 ELEVATE-PD study results
17d ago
AMRX
Premium
The Fly
Amneal Pharmaceuticals initiated with a Buy at UBS
20d ago
AMRX
Premium
The Fly
Amneal announces U.S. launch of two respiratory metered-dose inhalation products
23d ago
AMRX
Premium
Company Announcements
Amneal Pharmaceuticals Earnings Call: Growth Amid Transition
2M ago
AMRX
Premium
The Fly
Amneal Pharmaceuticals price target raised to $17 from $15 at Goldman Sachs
2M ago
AMRX
Premium
The Fly
Amneal Pharmaceuticals price target raised to $17 from $15 at Truist
2M ago
AMRX
Premium
The Fly
Truist ups Amneal Pharmaceuticals price target, says pullback great entry point
2M ago
AMRX
Premium
Ratings
Amneal Pharmaceuticals: Portfolio Shift to High-Margin Brands and Biosimilars Supports Buy Rating and Upside to $17 Target
2M ago
AMRX
Premium
Company Announcements
Amneal Posts Strong Q4 Results and Raises 2026 Outlook
2M ago
8K
AMRX
Premium
Market News
Options Volatility and Implied Earnings Moves Today, February 27, 2026
2M ago
HE
ABR
Premium
The Fly
Amneal Pharmaceuticals reports Q4 adjusted EPS 21c, consensus 18c
2M ago
AMRX
Premium
The Fly
Amneal Pharmaceuticals sees FY26 adjusted EPS 93c-$1.03, consensus 94c
2M ago
AMRX
Premium
Pre-Earnings
AMRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
AMRX
Premium
Company Announcements
Amneal Pharmaceuticals Refinances Term Loans, Lowers Interest Costs
3M ago
8K
AMRX
Premium
The Fly
Amneal Pharmaceuticals added to S&P SmallCap 600 Index
3M ago
AMRX
Premium
Company Announcements
Amneal Finalizes Nationwide Opioid Settlement Implementation Plan
3M ago
8K
AMRX
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
